Lastly, the upregulation of SNHG16 in bladder cancer was revealed; it negatively regulates miR-98 expression, which contributes to bladder cancer malignancy through the miR-98/STAT3/Wnt/β-catenin pathway axis. This evidence concerns the gene STAT3 and urinary bladder carcinoma.